Bill · H.R. 5158· House(119-HR-5158)
Fair Price Device Act
- Introduced
- 9/4/2025
- Last activity
- 9/4/2025 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- Hillary Scholten
- Cosponsors
- - 0 - 1
- Introduced
- In Committee
What this bill would do
The "Fair Price Device Act" amends the Federal Food, Drug, and Cosmetic Act. It specifically addresses the approval process for combination products that consist of a generic drug and a device. The bill updates the requirements for information that must be submitted to show that a new generic drug used with a device has the same safety profile and clinical effect as the listed drug.
Yes· 3 of 10
Would households on low incomes be better off under this?+5
Lower costs for essential combination drug-device products increase affordability for low-income patients.
Does this lower the price of prescription medicines?+5
By clarifying the approval process for generic combination products, the bill promotes competition which typically lowers drug prices.
Would people over 65 be better off under this?+3
Seniors often rely on multiple combination products and would benefit from lower-cost generic options.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
- Approval of Generic Combination Products: Section 2 allows for the submission of relevant information, including human factors studies and comparative analyses of the device and user interface, to show that a new drug for use with a device is safe and effective. This could potentially lead to more generic options for combination products.
Potential Negative Impacts for People
- Insufficient Information for Approval: Section 2(2)(C) specifies that an application may be deemed insufficient if the information submitted does not show that the new drug for use with the device can be expected to have the same clinical effect and safety profile as the listed drug.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Low Income Households+5Good For Middle Class Households+3Good For Retirees+3Good For Seniors+3Good For Business Owners+2Good For People With Disabilities+2
- Healthcare
- Reduces Prescription Drug Costs+5Improves Healthcare Access+3
- Economy And Finance
- Improves Consumer Protection+1Improves Economic Growth+1
- 9/15/2025
- 1 Cosponsor added.
- 9/4/2025
- Referred to the House Committee on Energy and Commerce.
- Introduced in House
Celeste MaloyRepublican · Utah